Intracranial Stents: Market Research Report

December 2014 | 94 pages | ID: I210F5F9ED1EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as -

• Admedes Schuessler GmbH
• BALT Extrusion
• Cardiatis SA
• Codman & Shurtleff, Inc.
• Covidien PLC

Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Growing Importance of Intracranial Stents in Neurovascular Disease

Table 1. Global Neurovascular Intervention Market by Technique (2014): Percentage Share Breakdown for Embolization, Revascularization, Support Devices, and Mechanical Thrombectomy (includes corresponding Graph/Chart)

The Global Intracranial Stents Market - Adversely Impacted by the SAMMPRIS Study
SAMMPRIS Study: An Insight
Rising Geriatric Population – A Major Growth Driver for the ICS Market

Table 2. Elderly Population (65+ Years) as a Percentage of the Total Population: 2000 & 2025 (includes corresponding Graph/Chart)

Table 3. Global Population Statistics for the 65+ Age Group: 2012 (includes corresponding Graph/Chart)

Table 4. Life Expectancy at Age 60 and 80 Years- (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)

Market Challenges
Technological Challenges
Safety and Efficacy
Regulatory Challenges
Price Factor

2. INTRACRANIAL STENTS AVAILABLE IN THE MARKET

APOLLO Stent System
WILLIS Intracranial Stent Graft System
Neuroform EZ Stent System
Wingspan Stent System
Self-Expandable LEO
Micrus Pharos Vitesse Intracranial Stent
Solitaire AB Neurovascular Remodeling Device

3. MARKET DRIVERS & TRENDS

Changing Lifestyle Conditions Stoking Risk of Cerebrovascular Diseases
Rising Stroke Statistics – An Opportunity Indicator
Rising Number of Restenosis Cases Boosts Demand for Stenting
Asians at Highest Risk of Intracranial Atherosclerosis Disease
Cardiovascular Stent Manufacturers Diversify Into the Neurovascular Market
QMRA Facilitates Detection of In-stent Stenosis
MNCs Weave Strategies to Tap Growth Centers in Emerging Markets
Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations
Rising Road Accidents Lead to Increasing Number of Stenting Procedures

Table 5. Global Rate of Road Fatalities by Economic Status of Countries (2014): Percentage Rate of Road Fatalities per 100,000 Residents for Low, Mid and High Per Capita Income Regions (includes corresponding Graph/Chart)

4. PRODUCT OVERVIEW

Intracranial Stenting
Stents
Evolution
Types of Stents
Bare Metal Stents (BMS)
Drug Eluting Stents
Self-Expanding Stents
Post-Treatment Management
Anti-Platelet Therapy
Surveillance Imaging

5. NEUROVASCULAR DISEASES - AN OVERVIEW

Introduction
Diagnosis of Intracranial Stenosis
Differential Diagnosis
Neuroimaging Screening
Anatomic Diagnosis
Digital Subtraction Angiography
Transcranial Doppler
Magnetic Resonance Angiography (MRA)
Positron Emission Tomography (PET)
Computerized Tomography (CT) Perfusion
Treatment Procedures for Intracranial Stenosis
Medication
Anticoagulants or Blood Thinners
Cholesterol Lowering Drugs
Blood Pressure Medications
Surgical Procedures
Stenting/Balloon Angioplasty
Cerebral Artery Bypass

6. MAJOR NEUROVASCULAR INDICATIONS REQUIRING STENTING PROCEDURES

Ischemic Stroke
Symptoms, Indications, and Complications Associated with Stroke
Posterior Circulation Stroke
Anterior Circulation Stroke
Non-Specific Signs
Some Major Risk Factors for Stroke
Intracranial Atherosclerotic Disease (ICAD)
Risk Factors
Treatment Options for ICAD
Brain Aneurysms/Cerebral Aneurysm/ Intracranial Aneurysm
Aneurysm – Quick Facts
Symptoms of Unruptured Aneurysm
Risk Factors for Aneurysm
Detection Methods

Table 6. Comparison of Sensitivity and Specificity of Computed Tomography Angiography (CTA), Transcranial Doppler Sonography (TCD) and Magnetic Resonance Angiography (MRA) in the Diagnosis of Intracranial Aneurysms (includes corresponding Graph/Chart)

Table 7. Percentage Mortality, Morbidity, and Re-bleeding Rate of Intervention Associated with Intracranial Aneurysms

Arterial Dissection
Diagnosis
Treatment
Restenosis

7. PRODUCT INTRODUCTIONS & APPROVALS

CFDA Approves New Specifications of MicroPort’s Apollo Stent System (China)
MicroPort’s WILLIS Intracranial Stent Graft System Receives China SFDA Approval
Phenox’s pCONus Bifurcation Aneurysm Implant Obtains CE-Mark Approval
Acandis’ Acclino 1. 9-F Stent System Receives CE Mark Approval
ITGI Medical Obtains CE Mark Approval for AneuGraft Nx

8. RECENT INDUSTRY ACTIVITY

MicroVention Enrolls in Clinical Trial for Its FRED System (US)
Admedes Schuessler to Expand Nitinol Manufacturing Capacity
STAR Study Results Establish Safety and Efficacy of Solitaire FR Device in Acute Ischemic Stroke Treatment
MicroPort Scientific Announces Inauguration of MicroPort NeuroTech
Purdue University Scientists Study Stents Coated with Nanotechnology-Enhanced Drug for Treatment of Aneurysms

9. FOCUS ON SELECT PLAYERS

Admedes Schuessler GmbH (Germany)
BALT Extrusion (France)
Cardiatis SA (Belgium)
Codman & Shurtleff, Inc. (US)
Covidien PLC (Ireland)
ITGI Medical Ltd. (Israel)
MicroPort Scientific Corporation (China)
OBEX Medical (New Zealand)
Stryker Corp. (US)

10. GLOBAL MARKET PERSPECTIVE

Table 8. World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 9. World Historic Review for Intracranial Stents by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart)

Table 10. World 14-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for the Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
The Largest Market for Intracranial Stents Globally
SAMMPRIS Study Results – A Major Blow to the US ICS Market
Ageing Demographics: A Key Market Driver

Table 11. North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)

Regulatory Status of Intracranial Stents in the United States
Intracranial Stenting among Medicare Beneficiaries during the Years 2006-2010
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 12. The US Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 13. The US Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart)

2. EUROPE

A. Market Analysis
Negative Effects of SAMMPRIS Study Expand to European Market
Increasing Geriatric Population Segment: A Business Case for ICS

Table 14. Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)

Focus on Select Regional Markets
France
French Government Imposes Regulations on Advertisement of High-risk Medical Devices
The United Kingdom
Stroke Statistics in the UK

Table 15. Breakdown of Total Number of Deaths Due to Strokes by Age and Sex in the UK: 2010 (includes corresponding Graph/Chart)

Product Approvals
Strategic Corporate Development
Select Key Players
B. Market Analytics

Table 16. European Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 17. European Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart)

3. REST OF WORLD

A. Market Analysis
Developing Regions Poised to Witness Faster Growth
Price Sensitivity of Asian Consumers – A Crucial Factor
India & China Offer Significant Growth Opportunities

Table 18. China and India Leads Global Population (July 2013): Table Depicting China and India’s Huge Population Vis-a-vis Other Countries’ Population (in Million) by Age Group (includes corresponding Graph/Chart)

Table 19. Age-wise Breakup of China and India’s Population Vis-à-vis Other Populous Countries Globally: As of July 2013 (includes corresponding Graph/Chart)

Select Regional Markets
Australia
Stroke Statistics in Australia

Table 20. Stroke Prevalence in Australia Age and Gender: 2012 (includes corresponding Graph/Chart)

Leading Risk Factors for Stroke-Related Fatalities: Ranking Based on Number of Deaths (2012)
China
Healthcare Reforms and New Product Approval to Propel Market Growth

Table 21. Chinese Neurovascular Stents Market by Leading Brand (2013): Percentage Market Share Breakdown of Units Sold for Apollo, Wingspan, and Others (includes corresponding Graph/Chart)

APOLLO – Tried and tested Stent System
WILLIS to Target Bright Market Prospects in China
India
Changes in Lifestyle Demographic and Socioeconomic Factors Increase Stroke Prevalence
Stroke Statistics
Management and Treatment of Stroke Presents a Daunting Task
Kerala – Gaining Prominence for Neurovascular Therapy
Japan
Japanese Intracranial Stents Market

Table 22. Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

Studies Validate Effectiveness of Endovascular Therapy for Treatment of Intracranial Aneurysm
Product Approvals
Strategic Corporate Development
Select Key Players
B. Market Analytics

Table 23. Rest of World Recent Past, Current & Future Analysis for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)

Table 24. Rest of World Historic Review for Intracranial Stents Market Analyzed with Annual Sales Figures in US$ Thousand for the Years 2006 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17)
The United States (6)
Europe (6)
  France (1)
  Germany (3)
  Rest of Europe (2)
Asia-Pacific (Excluding Japan) (4)
Middle East (1)